After expanding its Pact for a Healthier World program, Pfizer says it will provide a full portfolio of medicines and vaccines, including off-patent products, to 45 low-income countries on a non-profit basis.
Launched by the company in May 2022 to reduce health inequalities, the program initially includes 23 patented drugs available in the US or EU, including the COVID-19 drug Paxlovid and the breast cancer drug Ibrance. Pfizer’s commitment to include all vaccines was included.
With this expansion, the company now plans to offer 500 products to “better address the burden of disease and unmet patient needs” in the countries included in the programme.
Additional products will also be included in Accord’s portfolio on a non-commercial basis as the company launches new drugs and vaccines.
“This expansion of our product offering, coupled with our continued efforts to address barriers that limit or prevent access, will help us achieve and even advance our vision of a world where all people have access to the medicines and vaccines they need. Pfizer Chairman and Chief Executive Officer Albert Bourra said:
In a statement, Pfizer said in a statement that since its inception, the program “continues to make progress toward its goal of supporting global health equity initiatives through the supply of medicines and vaccines and strengthening health systems.” said.
Rwanda has already received nine of the company’s medicines and vaccines for the treatment of certain cancers, infectious diseases and inflammatory diseases.
In addition, working with the Ministry of Health of Rwanda, Pfizer will provide specialized healthcare education and training to support product delivery and to identify opportunities for long-term supply chain optimization, the first global health team was sent to the country.
Cooperation with the ministries of health of Malawi, Ghana and Senegal, as well as many other Member States, is also underway to develop a better understanding of medical needs and opportunities to strengthen health systems.
His Excellency Paul Kagame, President of Rwanda, said:
“Our expanded portfolio offering, coupled with our commitment to strengthening public health systems, will further advance our progress and provide valuable support for major national health initiatives that lead to positive health outcomes. increase.”